Home
Fasken
Dara Jospé
Dara Jospé
Fasken
Canada Announces Funding And Next Steps In Rare Disease Drug Strategy
12 Apr 2023 | Canada
Breaking News: PMPRB Opens Consultation On Draft Guidelines
12 Oct 2022 | Canada
PMPRB Interim Guidance Updated
26 Aug 2022 | Canada
New Recycling Obligations For Pharmaceutical Companies: Principle Of Extended Producer Responsibility Broadened To The Pharmaceutical Industry
24 Aug 2022 | Canada
Canada Introduces Regulatory Framework For Supplemented Foods
24 Aug 2022 | Canada
New Labelling Requirements For Natural Health Products
24 Aug 2022 | Canada
Sweet Or Savory? Expect New Front-of-package Nutrition Labelling For Certain Foods
22 Jul 2022 | Canada
National Pharmacare: CADTH Advisory Panel Releases Final Report On Pan-Canadian Formulary
15 Jul 2022 | Canada
Minister Of Health Unveils Quebec's Rare Diseases Policy
29 Jun 2022 | Canada
Breaking News From The WTO: Limited TRIPS Waiver For COVID-19 Vaccines
24 Jun 2022 | Canada
End To The RAMQ Fax: Implications & Ambiguity
16 Jun 2022 | Canada
Breaking PMPRB News: Another Win For Patients And The Innovative Pharmaceutical Industry
26 Apr 2022 | Canada
PMPRB Releases 2022-23 Departmental Plan In The Wake Of Successful Legal Challenges And Postponements
07 Apr 2022 | Canada
Key Takeaways From Ongoing PMPRB Litigation
02 Mar 2022 | Canada
Quebec Court Of Appeal Renders Major Decision On The PMPRB
22 Feb 2022 | Canada
A First Step To National Pharmacare? CADTH Invites Stakeholders To Comment On Potential Pan-Canadian Formulary Framework
16 Feb 2022 | Canada
Updated Industry Code: Innovative Medicines Canada Publishes Its 2022 Code Of Ethical Practices
08 Feb 2022 | Canada
The 2022 PMPRB Outlook For Pharmaceutical Patentees In Canada
25 Jan 2022 | Canada
Modernization Of The Quebec Food Products Act
24 Nov 2021 | Canada
Quebec Announces Mandatory Vaccination Policy For Healthcare Workers
04 Oct 2021 | Canada
< 1 2 3 >
20%
Very Popular: This author falls within the Top 20% for the below topics and industry categories
Based on Mondaq users readership, this author is ranked as VERY POPULAR in Canada for the topics, user groups and industry sectors listed below*:
Topics
  • Intellectual Property
  • Patent
  • Food and Drugs Law
  • Corporate and Company Law
  • Corporate/Commercial Law
  • Food, Drugs, Healthcare, Life Sciences
  • Life Sciences, Biotechnology & Nanotechnology
* Rankings are based on analysis of the last 12 months of Mondaq readership data across more than 25,000 contributing authors. To be ranked ‘Very Popular’ an author must be in the top 20% of results within the selected criteria.
Canada | Intellectual Property
PMPRB Interim Guidance Updated
Canada | Food, Drugs, Healthcare, Life Sciences
PMPRB Interim Guidance Updated
Contact Details
Montreal
The Stock Exchange Tower,PO Box 242
Suite 3700
800 Victoria Square
Montreal QC H4Z 1E9
Canada
Telephone: 1-1514-3977400

  © Mondaq® Ltd 1994 - 2023. All Rights Reserved.